CD14 and neoplasm: Most importantly, combined STAT3 and p38 inhibition supported a shift from CD14+ monocyte-like cells to CD1a+ DC in metastatic melanoma single-cell suspensions, indicating a potential for improved DC differentiation in the tumor microenvironment (32).